Consistent with previous reports, we confirmed that high TM4SF1 expression is associated with basal tumor signatures (Supplementary Fig. 10A) and adverse clinical outcomes in TCGA-BLCA (Supplementary Fig. 10B, C)38. Here, TM4SF1 is linked to neoplasm.